Finally, transfer of serum from mice that received rmInα primed CD4+ T cells also provided significant protection (P = 0.001) against the growth of I-10 TSC tumors (Fig. 3g) and significantly enhanced (P = 0.001) overall survival (Fig. 3h). Here, CD4 is linked to tuberous sclerosis.